{"id":1490,"date":"2026-09-04T09:15:43","date_gmt":"2026-09-04T07:15:43","guid":{"rendered":"https:\/\/amyloidosisalliance.local\/comite-scientifique\/"},"modified":"2026-09-29T11:06:38","modified_gmt":"2026-09-29T09:06:38","slug":"comite-scientifique","status":"publish","type":"page","link":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/","title":{"rendered":"Comit\u00e9 scientifique"},"content":{"rendered":"\n<nav aria-label=\"Breadcrumb\" class=\"wp-block-group aa-breadcrumb is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"aa-inner\"><a href=\"\/\">Accueil<\/a><span class=\"aa-breadcrumb__sep\">\u203a<\/span><a href=\"https:\/\/www.amyloidosisalliance.org\/fr\/a-propos\/\">L\u2019Alliance<\/a><span class=\"aa-breadcrumb__sep\">\u203a<\/span><span class=\"aa-breadcrumb__current\">Comit\u00e9 scientifique<\/span><\/div>\n<\/nav>\n\n<section class=\"wp-block-group aa-page-hero is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-page-hero__grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-overline wp-block-paragraph\">L\u2019Alliance<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Comit\u00e9 scientifique<\/h1>\n\n\n\n<p class=\"aa-lead wp-block-paragraph\">D\u00e9couvrez les cliniciens et chercheurs de premier plan qui orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et valident nos publications.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-page-hero__photo is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1710\" height=\"1698\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\" alt=\"\" class=\"wp-image-757\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg 1710w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-300x298.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-1024x1017.jpg 1024w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-150x150.jpg 150w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-768x763.jpg 768w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-1536x1525.jpg 1536w\" sizes=\"auto, (max-width: 1710px) 100vw, 1710px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section class=\"wp-block-group aa-anchorband aa-anchorband--stats is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-columns aa-anchor-cols is-layout-flex wp-container-core-columns-is-layout-b2e659ba wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column aa-anchor-item is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"num wp-block-paragraph\">8<\/p>\n\n\n\n<p class=\"lbl wp-block-paragraph\">Experts<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column aa-anchor-item is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"num wp-block-paragraph\">6<\/p>\n\n\n\n<p class=\"lbl wp-block-paragraph\">Pays<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section id=\"committee\" class=\"wp-block-group aa-section aa-section--cream aa-sc is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-team-head is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-eyebrow wp-block-paragraph\">Expertise m\u00e9dicale<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Qui sont-ils<\/h2>\n<\/div>\n\n\n\n<p class=\"aa-team-head__text wp-block-paragraph\">Huit cliniciens et chercheurs de six pays, qui couvrent les diff\u00e9rents visages de l\u2019amylose\u00a0: cardiaque, h\u00e9matologique, neurologique, r\u00e9nal et inflammatoire.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore.jpg\" alt=\"Julian Gillmore, portrait\" class=\"wp-image-634\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Royaume-Uni<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Julian Gillmore<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Le professeur Julian Gillmore est professeur de m\u00e9decine \u00e0 l\u2019University College London et n\u00e9phrologue consultant honoraire au Royal Free Hospital. Il dirige l\u2019UCL Centre for Amyloidosis et la recherche du National Amyloidosis Centre britannique. Form\u00e9 \u00e0 la n\u00e9phrologie, il a obtenu un MD et un PhD dans le domaine de l\u2019amylose. Ses recherches portent sur la physiopathologie, le diagnostic et le traitement des amyloses syst\u00e9miques, avec une expertise particuli\u00e8re de l\u2019amylose \u00e0 transthyr\u00e9tine.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema.jpg\" alt=\"Monique Minnema, portrait\" class=\"wp-image-635\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Pays-Bas<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Monique Minnema<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">La professeure Monique Minnema est professeure d\u2019h\u00e9matologie et interniste-h\u00e9matologue \u00e0 l\u2019UMC Utrecht. Elle est sp\u00e9cialis\u00e9e dans les h\u00e9mopathies malignes B, en particulier les maladies plasmocytaires, dont le my\u00e9lome multiple et l\u2019amylose AL, ainsi que la macroglobulin\u00e9mie de Waldenstr\u00f6m. Elle dirige l\u2019\u00e9quipe de recherche clinique en h\u00e9matologie et la biobanque d\u2019h\u00e9matologie de l\u2019UMC Utrecht. Sa recherche clinique porte sur le d\u00e9veloppement de nouvelles th\u00e9rapies cellulaires et m\u00e9dicamenteuses pour les maladies plasmocytaires et les autres h\u00e9mopathies malignes B.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy.jpg\" alt=\"Thibaud Damy, portrait\" class=\"wp-image-636\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">France<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Thibaud Damy<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Le professeur Thibaud Damy est professeur de cardiologie et chef de l\u2019unit\u00e9 insuffisance cardiaque et cardiomyopathies de l\u2019Assistance Publique \u2013 H\u00f4pitaux de Paris. Il dirige \u00e9galement le Centre de r\u00e9f\u00e9rence fran\u00e7ais de l\u2019amylose cardiaque au sein de la fili\u00e8re Cardiogen. Il a fond\u00e9 en 2009 le R\u00e9seau Amylose Mondor, une structure pluridisciplinaire consacr\u00e9e au diagnostic et \u00e0 la prise en charge de l\u2019amylose. Ses travaux cliniques et de recherche portent sur l\u2019insuffisance cardiaque et l\u2019amylose cardiaque, notamment le diagnostic pr\u00e9coce, l\u2019imagerie, les biomarqueurs et le traitement. Depuis 2010, il coordonne le R\u00e9seau Amylose, r\u00e9seau national fran\u00e7ais de prise en charge et d\u2019orientation de l\u2019amylose, et il co-coordonne le r\u00e9seau de recherche clinique F-CRIN GRACE consacr\u00e9 \u00e0 l\u2019amylose cardiaque.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici.jpg\" alt=\"Laura Obici, portrait\" class=\"wp-image-637\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Italie<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Laura Obici<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">La docteure Laura Obici est m\u00e9decin consultante \u00e0 l\u2019unit\u00e9 des maladies rares et au Centre de recherche et de traitement de l\u2019amylose de l\u2019IRCCS Fondazione Policlinico San Matteo, \u00e0 Pavie (Italie). Ses activit\u00e9s cliniques et de recherche portent sur les amyloses syst\u00e9miques, notamment l\u2019amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine et l\u2019amylose inflammatoire. Elle a une grande exp\u00e9rience du diagnostic et du traitement des formes h\u00e9r\u00e9ditaires d\u2019amylose et a contribu\u00e9 \u00e0 des travaux de recherche et \u00e0 des \u00e9tudes cliniques internationales dans ce domaine.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes.jpg\" alt=\"F&#xE1;bio Fernandes, portrait\" class=\"wp-image-638\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Br\u00e9sil<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">F\u00e1bio Fernandes<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Le docteur F\u00e1bio Fernandes est professeur adjoint de cardiologie \u00e0 la facult\u00e9 de m\u00e9decine de l\u2019Universit\u00e9 de S\u00e3o Paulo et chef de l\u2019unit\u00e9 des cardiomyopathies de l\u2019Institut du c\u0153ur (InCor) de l\u2019Universit\u00e9 de S\u00e3o Paulo, au Br\u00e9sil. Ses activit\u00e9s cliniques et de recherche portent sur les cardiomyopathies, l\u2019insuffisance cardiaque et l\u2019amylose cardiaque, avec une expertise particuli\u00e8re de la cardiomyopathie amylo\u00efde \u00e0 transthyr\u00e9tine. Il a une grande exp\u00e9rience du diagnostic et de la prise en charge des patients atteints d\u2019amylose cardiaque et a contribu\u00e9 \u00e0 de nombreux projets de recherche nationaux et internationaux dans ce domaine.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle.jpg\" alt=\"Sophie Georgin-Lavialle, portrait\" class=\"wp-image-639\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">France<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Sophie Georgin-Lavialle<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">La professeure Sophie Georgin-Lavialle est professeure de m\u00e9decine interne et d\u2019immunologie clinique \u00e0 Sorbonne Universit\u00e9 et \u00e0 l\u2019h\u00f4pital Tenon (AP-HP), \u00e0 Paris. Elle coordonne le volet adulte du Centre de r\u00e9f\u00e9rence des maladies auto-inflammatoires et de l\u2019amylose inflammatoire. Ses activit\u00e9s cliniques et de recherche portent sur les maladies auto-inflammatoires, dont la fi\u00e8vre m\u00e9diterran\u00e9enne familiale, le syndrome VEXAS et l\u2019amylose AA. Depuis 2025, elle est responsable de la th\u00e9matique maladies auto-inflammatoires au sein du r\u00e9seau europ\u00e9en de r\u00e9f\u00e9rence ERN RITA.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia.jpg\" alt=\"Pablo Garc&#xED;a-Pav&#xED;a, portrait\" class=\"wp-image-640\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Espagne<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Pablo Garc\u00eda-Pav\u00eda<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Le docteur Garc\u00eda-Pav\u00eda dirige l\u2019unit\u00e9 d\u2019insuffisance cardiaque et de cardiopathies h\u00e9r\u00e9ditaires du service de cardiologie de l\u2019Hospital Universitario Puerta de Hierro, \u00e0 Madrid. En plus de son activit\u00e9 hospitali\u00e8re, il est professeur de recherche au Centre national espagnol de recherche cardiovasculaire (CNIC) et r\u00e9dacteur en chef adjoint de la Revista Espa\u00f1ola de Cardiolog\u00eda. Ses recherches portent sur les cardiomyopathies h\u00e9r\u00e9ditaires, l\u2019insuffisance cardiaque et l\u2019amylose, et il a publi\u00e9 plus de 350 articles dans des revues \u00e0 comit\u00e9 de lecture, dont The New England Journal of Medicine, European Heart Journal, Journal of the American College of Cardiology, Circulation, Nature Communications, Nature Medicine et The Lancet.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz.jpg\" alt=\"M&#xE1;rcia Waddington-Cruz, portrait\" class=\"wp-image-641\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Br\u00e9sil<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">M\u00e1rcia Waddington-Cruz<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">La docteure M\u00e1rcia Waddington-Cruz est titulaire d\u2019un master et d\u2019un doctorat en neurologie de la FM-UFRJ, et sp\u00e9cialiste en neurophysiologie clinique certifi\u00e9e par la SBNC\/AMB. Elle est professeure au programme de troisi\u00e8me cycle en m\u00e9decine clinique de la FM-UFRJ, Universit\u00e9 f\u00e9d\u00e9rale de Rio de Janeiro. Elle est investigatrice principale au Centre de r\u00e9f\u00e9rence de l\u2019amylose CEPARM de l\u2019h\u00f4pital universitaire de l\u2019UFRJ, coordinatrice de la fili\u00e8re de soins de l\u2019amylose au complexe hospitalier Am\u00e9ricas-Vit\u00f3ria-Samaritano Barra (Rio de Janeiro), et investigatrice principale \u00e0 l\u2019American Institute of Science and Education.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section class=\"wp-block-group aa-next aa-next--split is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-next__head is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-section-num wp-block-paragraph\">Aller plus loin<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Explorer l\u2019Alliance<\/h2>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-next__grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-next-card is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.amyloidosisalliance.org\/fr\/lequipe\/\">L\u2019\u00e9quipe<\/a><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">D\u00e9couvrez le conseil d\u2019administration, l\u2019\u00e9quipe ex\u00e9cutive et les groupes de travail qui font vivre l\u2019Alliance au quotidien.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-next-card is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.amyloidosisalliance.org\/fr\/nos-missions\/\">Nos missions<\/a><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">D\u00e9couvrez les actions que m\u00e8ne l\u2019Alliance pour am\u00e9liorer le diagnostic, la prise en charge et la reconnaissance de l\u2019amylose.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-next-card is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.amyloidosisalliance.org\/fr\/ressources\/bibliotheque\/\">Biblioth\u00e8que<\/a><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Parcourez les guides valid\u00e9s, les fiches d\u2019information et les outils con\u00e7us pour les patients et les professionnels de sant\u00e9.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Accueil\u203aL\u2019Alliance\u203aComit\u00e9 scientifique L\u2019Alliance Comit\u00e9 scientifique D\u00e9couvrez les cliniciens et chercheurs de premier plan qui orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et valident nos publications. 8 Experts 6 Pays Expertise m\u00e9dicale Qui sont-ils Huit cliniciens et chercheurs de six pays, qui couvrent les diff\u00e9rents visages de l\u2019amylose\u00a0: cardiaque, h\u00e9matologique, neurologique, r\u00e9nal et inflammatoire. Royaume-Uni Julian Gillmore [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1490","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Experts de l\u2019amylose\u00a0: notre comit\u00e9 scientifique<\/title>\n<meta name=\"description\" content=\"Des cliniciens et chercheurs de six pays orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et relisent les informations publi\u00e9es sur ce site.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Experts de l\u2019amylose\u00a0: notre comit\u00e9 scientifique\" \/>\n<meta property=\"og:description\" content=\"Des cliniciens et chercheurs de six pays orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et relisent les informations publi\u00e9es sur ce site.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-29T09:06:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1710\" \/>\n\t<meta property=\"og:image:height\" content=\"1698\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/\",\"name\":\"Experts de l\u2019amylose\u00a0: notre comit\u00e9 scientifique\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\",\"datePublished\":\"2026-09-04T07:15:43+00:00\",\"dateModified\":\"2026-09-29T09:06:38+00:00\",\"description\":\"Des cliniciens et chercheurs de six pays orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et relisent les informations publi\u00e9es sur ce site.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/comite-scientifique\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comit\u00e9 scientifique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Experts de l\u2019amylose\u00a0: notre comit\u00e9 scientifique","description":"Des cliniciens et chercheurs de six pays orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et relisent les informations publi\u00e9es sur ce site.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/","og_locale":"fr_FR","og_type":"article","og_title":"Experts de l\u2019amylose\u00a0: notre comit\u00e9 scientifique","og_description":"Des cliniciens et chercheurs de six pays orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et relisent les informations publi\u00e9es sur ce site.","og_url":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_modified_time":"2026-09-29T09:06:38+00:00","og_image":[{"width":1710,"height":1698,"url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@amyloidosisa","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/","url":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/","name":"Experts de l\u2019amylose\u00a0: notre comit\u00e9 scientifique","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/#primaryimage"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/#primaryimage"},"thumbnailUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg","datePublished":"2026-09-04T07:15:43+00:00","dateModified":"2026-09-29T09:06:38+00:00","description":"Des cliniciens et chercheurs de six pays orientent les priorit\u00e9s m\u00e9dicales de l\u2019Alliance et relisent les informations publi\u00e9es sur ce site.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/#primaryimage","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/comite-scientifique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.amyloidosisalliance.org\/fr\/"},{"@type":"ListItem","position":2,"name":"Comit\u00e9 scientifique"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#website","url":"https:\/\/www.amyloidosisalliance.org\/fr\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/pages\/1490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/comments?post=1490"}],"version-history":[{"count":1,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/pages\/1490\/revisions"}],"predecessor-version":[{"id":1491,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/pages\/1490\/revisions\/1491"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/media?parent=1490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}